Observational study evaluates orthostatic hypotension prevalence and comorbidities in hospitalized hypertensive patients, indicating significant associations.
Background: Orthostatic hypotension (OH) is defined as a sustained reduction in systolic blood pressure of at least 20 mmHg or a reduction in diastolic blood pressure of at least 10 mmHg, usually within the first 3 minutes of standing. Aim: To evaluate the prevalence of OH and associated comorbidities in hypertensive patients hospitalized in Internal Medicine Units. Materials and Methods: An Italian observational, multicenter, prospective study (IpOp study) included 1000 hypertensive patients hospitalized in 29 Units of Internal Medicine and followed for 36 months. Demographic and clinical data, blood pressure measures and blood tests were recorded at baseline. Results: The overall prevalence of OH in our study was 25.1%. Syncope was associated with OH (RR 1.76; 95%CI 1.19-2.60; p=0.005), while other symptoms were not. Parkinson’s disease (RR 3.72; 95%CI 2.42-5.72; p<0.0001), type 1 diabetes mellitus (RR 2.24; 95%CI 1.28-3.93; p=0.005) and α2-blocker drugs (RR 1.52; 95%CI 1.13-2.04; p=0.006) were associated with OH. Respiratory comorbidities resulted associated with OH (RR 1.52; 95%CI 1.10-2.09; p=0.01), whereas cardiovascular disease, anemia, chronic kidney disease and other antihypertensive drugs, cognitive impairment and frailty were not. Conclusions: The IpOp study confirms the association between OH and syncope, Parkinson’s disease, type 1 diabetes mellitus and use of α2 antagonists. Moreover, also respiratory comorbidities were associated with OH. The follow-up reporting the onset of new falls, major cardiovascular events and deaths is still ongoing.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: